Human Genome Sciences, Inc.
Human Genome Sciences Announces Proposed Public Offering of Common Stock
Published in Drug Law Weekly, August 11th, 2009
Human Genome Sciences, Inc. (NASDAQ:HGSI) announced that it has commenced an underwritten public offering of up to 18,000,000 shares of its common stock. The Company intends to grant the underwriters a 30-day option to purchase up to an additional 2,700,000 shares of the Company's common stock. The shares will be issued pursuant to a prospectus supplement filed as part of a shelf registration statement previously filed with the Securities and Exchange Commission on Form S-3.
The Company intends to use net proceeds from the offering for general corporate purposes, including clinical trial, research and development, general and administrative and manufacturing expenses,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
Source: Drug Law Weekly (2009-08-11)
More Articles from Drug Law Weekly
- Autism
Judge Sues Blue Cross for Autism Treatment - BioScrip, Inc.
BioScrip to Present at BMO Capital Markets 9th Annual Focus on Healthcare Conference - Biotechnology Business
Amgen's Second Quarter 2009 Adjusted Earnings Per Share Increased 13 Percent To $1.29 - Breast Cancer
Estrogen Getting Cool Reception From Dermatologists for Mixed Results in Improving Appearance of Skin - Clinical Trial Research
Clinical Trial by Licensee Does Not Meet Primary Endpoint - Colon Cancer
Patient Advocacy Groups Urge Congress and President to Preserve Access to Medical Imaging - More from this issue of Drug Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
